Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2017, Article ID 8596781, 4 pages
https://doi.org/10.1155/2017/8596781
Case Report

Neuromyelitis Optica in a Nepalese Man

Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal

Correspondence should be addressed to Utsav Joshi; moc.liamg@hu.ihsojvastu

Received 2 June 2017; Accepted 12 July 2017; Published 8 August 2017

Academic Editor: Samuel T. Gontkovsky

Copyright © 2017 Yogesh Subedi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Wingerchuk, W. F. Hogancamp, P. C. O'Brien, and B. G. Weinshenker, “The clinical course of neuromyelitis optica (devic's syndrome),” Neurology, vol. 53, no. 5, pp. 1107–1114, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Yamasaki, J.-I. Kira, T. Kanai et al., “Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders,” Annals of Neurology, vol. 40, no. 4, pp. 569–574, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-I. Kira, “Multiple sclerosis in the Japanese population,” The Lancet Neurology, vol. 2, no. 2, pp. 117–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Wingerchuk, B. Banwell, J. L. Bennett et al., “International consensus diagnostic criteria for neuromyelitis optica spectrum disorders,” Neurology, vol. 85, no. 2, pp. 177–189, 2015. View at Publisher · View at Google Scholar
  5. D. M. Wingerchuk, V. A. Lennon, S. J. Pittock, C. F. Lucchinetti, and B. G. Weinshenker, “Revised diagnostic criteria for neuromyelitis optica,” Neurology, vol. 66, no. 10, pp. 1485–1489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Wingerchuk and B. G. Weinshenker, “Neuromyelitis optica,” Current Treatment Options in Neurology, vol. 10, no. 1, pp. 55–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Takahashi, K. Fujihara, I. Nakashima et al., “Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre,” Brain, vol. 130, no. 5, pp. 1235–1243, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. W. C. Chia, J. N. Wang, and M. C. Lai, “Neuromyelitis optica: a case report,” Pediatrics & Neonatology, vol. 51, no. 6, pp. 347–352, 2010. View at Publisher · View at Google Scholar
  9. M. A. Lana-Peixoto, “Devic's neuromyelitis optica: a critical review,” Arquivos de Neuro-Psiquiatria, vol. 66, no. 1, pp. 120–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Furutani, M. Hata, K. Miyamoto, Y. Moribata, and N. Yoshimura, “A case of neuromyelitis optica masquerading as miller fisher syndrome,” Case Reports in Neurology, vol. 6, no. 3, pp. 226–231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Jarius, K. Ruprecht, B. Wildemann et al., “Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients,” Journal of Neuroinflammation, vol. 9, article 14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Langille and J. Desai, “Multisystem involvement in neuromyelitis optica,” Annals of Indian Academy of Neurology, vol. 18, pp. S56–S58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Waters, M. Reindl, A. Saiz et al., “Multicentre comparison of a diagnostic assay: Aquaporin-4 antibodies in neuromyelitis optica,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 87, no. 9, pp. 1005–1015, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Kowarik, J. Soltys, and J. L. Bennett, “The treatment of neuromyelitis optica,” Journal of Neuro-Ophthalmology, vol. 34, no. 1, pp. 70–82, 2014. View at Publisher · View at Google Scholar · View at Scopus